Pursuant to Regulation 30 and 33 read with schedule III of the SEBI (LODR) Regulations, 2015, we hereby inform you that the BOD at their meeting held on 30.05.2025 inter alia, considered ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aanchal Ispat reported audited results for FY25 with revenue from operations rising ~44% YoY to ₹15,130 lakhs (vs ₹10,535 lakhs in FY24), but the company posted a net loss of ₹1,340 lakhs (vs ₹625 lakhs loss in FY24), driven by large exceptional items. These included a ₹5,086 lakh write-off of irrecoverable trade receivables, loans and advances, and ₹107 lakhs of CIRP costs, partly offset by a ₹3,938 lakh gain from liability settlement under the NCLT-approved resolution plan. The company's Corporate Insolvency Resolution Process (CIRP), which began in September 2023, concluded with the NCLT approving the resolution plan on 27 March 2025, handing control to successful applicant Mukesh Goel. The auditor flagged multiple Emphasis of Matter paragraphs covering going concern uncertainty, absence of CFO and Company Secretary during the year, declining net worth over five years, and heavy dependence on related-party transactions with sister concern Maina International Ltd (91% of purchases and 87% of sales).
For shareholders: The revenue growth is encouraging, but the company remains loss-making with negative operating cash flow (₹268 lakhs outflow vs ₹630 lakhs inflow last year) and a sharply reduced net worth of just ₹345 lakhs. The NCLT resolution plan offers a potential revival path with capital restructuring and fresh equity infusion pending, but implementation risks remain and most accounting adjustments are still to be recorded. The stock is likely to remain volatile and speculative given the distressed background.